To assess the immunomodulatory potential of Vitamin-D in cervical cancer patients

INTERVENTION: Intervention1: Oral supplementation of Vitamin‐D gummies: Vitamin‐D supplementation in cervical cancer patients to aid and assess in the immunomodulatory potential of vitamin‐D Intervention2: Vitamin‐D oral supplements: Supplementation of 600 IU of Vitamin D to cervical cancer patients and assessing their prognosis The study duration is for a total of 18 months Control Intervention1: NIL: NIL CONDITION: Health Condition 1: C539‐ Malignant neoplasm of cervi Xuteri, unspecified PRIMARY OUTCOME: identify the vitamin D deficiency in cervical cancer patients ; understanding the immune potential of vitamin DTimepoint: assessment will be done at regular intervals ; 1. at 0 day ‐ start of the trial ; 2. after 1 month as mid‐interventition analysis ; 3. after 3 months by the end of the trial ensuring the adequacy and safety SECONDARY OUTCOME: NILTimepoint: NIL INCLUSION CRITERIA: Histologically confirmed cervical cancer in females aged between 20 years to 80 years with serum vitamin D levels less than 20ng per ml